APA (7th ed.) Citation

Tolaney, S., Jiang, Z., Zhang, Q., Barroso-Sousa, R., Park, Y. H., Rimawi, M. F., . . . Loibl, S. (2025). Trastuzumab Deruxtecan plus Pertuzumab for HER2-positive metastatic breast cancer. The New England journal of medicine. https://doi.org/10.1056/NEJMoa2508668

Chicago Style (17th ed.) Citation

Tolaney, Sara, et al. "Trastuzumab Deruxtecan Plus Pertuzumab for HER2-positive Metastatic Breast Cancer." The New England Journal of Medicine 2025. https://doi.org/10.1056/NEJMoa2508668.

MLA (9th ed.) Citation

Tolaney, Sara, et al. "Trastuzumab Deruxtecan Plus Pertuzumab for HER2-positive Metastatic Breast Cancer." The New England Journal of Medicine, 2025, https://doi.org/10.1056/NEJMoa2508668.